Skip to main content
Premium Trial:

Request an Annual Quote

Roche, UCLA Ink Biomarker Research Collaboration

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche said today that it will provide researchers at the University of California, Los Angeles with a range of its genomics tools in a new collaboration to study stem cells and cancer and to develop new targets and biomarkers for disease diagnostics and therapeutics.

Under the agreement, Roche will provide microarray systems from Roche NimbleGen, high-throughput screening tools, genetic expression profilers, and exome sequencing technologies to UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Jonsson Comprehensive Cancer Center.

Roche also will provide UCLA with reagents and technology and bioinformatics support for developing new predictive biomarkers. The firm's scientists also will work collaboratively with the university to develop new tools for both academic and commercial use.

"By working together at an early stage, we can optimize the technologies and provide the necessary support to improve detection and analysis, and ultimately, the success rate of biomarker discovery," Robert Yates, Head of Roche Applied Science, said in a statement.

"Discoveries made by UCLA scientists while working with the technologies will help provide Roche scientists with insight on academic research and can be used to refine Roche operations or develop new applications for the equipment," added Michael Teitell, a Broad and Jonsson center researcher.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.